Data / Form D filings / Alessa Therapeutics, Inc.
Alessa Therapeutics, Inc.: Form D filings
Alessa Therapeutics, Inc., a health care company in San Carlos, CA, filed 3 Form D notices with the SEC between 2019 and 2025. The latest, on May 1, 2025, reports $25.4 million sold of a $31.6 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 930 BRITTAN AVENUE, San Carlos, CA, 94070
- Phone
- (650) 223-5912
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1771653
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | New notice | $31,616,096 | $25,376,457 | $6,239,639 | 14 | Apr 18, 2025 | sec.gov |
| Jan 2, 2020 | New notice | $3,499,999 | $3,264,998 | $235,001 | 2 | Dec 19, 2019 | sec.gov |
| Mar 26, 2019 | New notice | $3,499,999 | $2,999,999 | $500,000 | 2 | Mar 11, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Zachary Collins | Executive Officer | |
| Cam Gallagher | Executive Officer, Director | |
| Steve Tregay | Director | |
| Douglas Crawford | Director | |
| Annie Mitsak | Director | |
| Richard Lim | Director | |
| Pamela Munster | Director |
Other health care companies in California that filed recently
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
Every Form D from the week of Apr 28, 2025 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Alessa Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.